Trials / Not Yet Recruiting
Not Yet RecruitingNCT07097974
Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- TCI Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the effects of the combined formula WM Formula, used as a dietary supplement, with a focus on improvements in glycemic and lipid parameters, body composition, and gut microbiota profiles.
Detailed description
This study is a single-center, randomized, double-blind, placebo-controlled human clinical trial designed to evaluate the potential effect of the WM Formula composite supplement on body weight. Eligible participants will be adults aged 18 years or older, screened based on waist circumference or body fat percentage. Participants will be randomly assigned to one of two groups: one receiving the combined formula WM Formula, and the other receiving a placebo. Each group will take either the WM Formula or placebo, and undergo regular assessments throughout the 4-week study period. Physiological parameters (e.g., height, weight, blood pressure, BMI) and biochemical markers (including liver and kidney function, lipid profile, and blood glucose levels) will be collected at baseline (Week 0), Week 2, and Week 4. In addition, participants will complete appetite assessment questionnaires and other surveys to evaluate changes in appetite and gastrointestinal symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | WM formula liquid drink | One glass jar (50 g) of the WM formula liquid drink was administered once daily, 1 hour prior to the first meal of the day. |
| DIETARY_SUPPLEMENT | Placebo | One glass jar (50 g) of the placebo liquid drink was administered once daily, 1 hour prior to the first meal of the day. |
Timeline
- Start date
- 2025-08-31
- Primary completion
- 2025-11-30
- Completion
- 2025-12-31
- First posted
- 2025-08-01
- Last updated
- 2025-08-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07097974. Inclusion in this directory is not an endorsement.